Integrated Biopharma, Inc.
INBP
$0.3069
$0.01194.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 928.00K | 430.00K | 112.00K | -116.00K | -385.00K |
| Total Depreciation and Amortization | 1.26M | 1.24M | 1.22M | 1.20M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 659.00K | 525.00K | 354.00K | 330.00K | 272.00K |
| Change in Net Operating Assets | -531.00K | -1.91M | -744.00K | -1.47M | -1.32M |
| Cash from Operations | 2.32M | 287.00K | 943.00K | -57.00K | -230.00K |
| Capital Expenditure | -576.00K | -571.00K | -553.00K | -425.00K | -96.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1.00K | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -576.00K | -571.00K | -553.00K | -424.00K | -95.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -28.00K | -39.00K | -42.00K | -41.00K | -41.00K |
| Issuance of Common Stock | 18.00K | 0.00 | 13.00K | 13.00K | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.00K | -39.00K | -29.00K | -28.00K | -28.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.73M | -323.00K | 361.00K | -509.00K | -353.00K |
